Biology Atlas

Map / Concepts

concept · intermediate · partly written

Epigenome editing

Epigenome editing writes or removes a chromatin mark at one chosen gene with a programmable protein, which is the main interventional test of whether a mark can hold a gene state.

Also called: targeted epigenetic editing, CRISPRoff, hit-and-run epigenetic silencing

What exists

Four studies are opened here: Amabile 2016 (three genes silenced in cells), Liu 2016 (methylation edited at named loci, including in mice), Nunez 2021 (CRISPRoff) and Cappelluti 2024 (mouse liver). All edit one gene or a few, in cells or mouse. 1234

Reported, not yet replicated

Silencing that outlasts the editor more

Amabile et al. (2016): transient expression of combinations of engineered repressors that synergise at the target locus instructed repressive histone marks and de novo DNA methylation, silencing three highly expressed genes in somatic cells. Silencing was highly specific, confined to the targeted locus without spreading, resistant to activation by cytokine stimulation, and relieved only by targeted DNA demethylation.

Nunez et al. (2021): CRISPRoff, a single dead-Cas9 fusion that establishes DNA methylation and repressive histone modifications, produced gene repression maintained through cell division and through differentiation of stem cells to neurons, including at genes lacking canonical CpG islands. 13

Reported, not yet replicated

Editing methylation changes expression more

Liu et al. (2016): fusions of dCas9 with Tet1 or Dnmt3a edited methylation at chosen sites. Demethylating the BDNF promoter IV or the MyoD distal enhancer raised expression; methylating a CTCF loop anchor blocked CTCF binding, interfered with looping and altered expression in the neighbouring loop; editing worked in mice as well (abstract). This is an interventional link between methylation and expression at those loci. 2

Reported, not yet replicated

Single effectors fade; combinations last more

The Amabile 2016 abstract reports that combinations of repressors that synergise were needed for stable silencing, and our source check, reading the full text, recorded that a single effector was not enough. The same pattern is described for single-effector editors elsewhere, but that source (a commentary) was not opened here. Treat the general statement as supported at this one study. 1

Reported, not yet replicated

How long: the sourced durations more

In mouse liver a single dose of lipid-nanoparticle-delivered zinc-finger editors almost halved circulating PCSK9 for nearly a year, and the silencing and repressive marks persisted after forced liver regeneration, which the authors take as support for heritability of the new state (Cappelluti et al. 2024, abstract). In culture, follow-up was to about 200 days (Amabile, full text per the checker). What is not shown: that silencing lasts for the life of an animal, that it is complete, or that it reverts or not on its own. 41

Reported, not yet replicated

A human result is reported by trade press only more

A trade-press article relays phase I results announced by a company at a liver-disease congress. No peer-reviewed report of that result was cited by the article and none was opened here, so no figure is used and the claim is not established. 5

Unverified: from our own report, source not opened

Plain answer

A DNA-binding protein, guided to a gene, carries enzymes that add repressive marks or remove methylation. In published work a short burst of the editor silenced genes stably through cell division in culture, was confined to the target gene, and could be reversed by targeted demethylation. In mouse liver one dose halved a circulating protein for nearly a year. Single editors tended to fade; combinations lasted. 134

Reported, not yet replicated

Why it matters

These are the experiments that show a mark can do work, rather than only being found beside a gene. They also show how long engineered silencing lasts and whether it can be undone. 14

Reported, not yet replicated

Real numbers

Mouse liver silencing of Pcsk9

A single administration of lipid nanoparticles carrying the editors almost halved circulating PCSK9 for nearly one year in mice, and silencing and repressive marks persisted after forced liver regeneration. A halving, not an abolition. 4

Reported, not yet replicated

Longest culture follow-up in Amabile 2016

Cells were followed to about 200 days (full-text figure as read by our source check; not in the abstract). 1

Reported, not yet replicated

Still open here

Not yet written: Equation.

Linked from

Sources

  1. Amabile, A., Migliara, A., Capasso, P., et al.. Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell (2016). paper; opened 2026-11-17 all records citing this
  2. Liu, X.S., Wu, H., Ji, X., et al.. Editing DNA methylation in the mammalian genome. Cell (2016). paper; opened 2026-11-17 all records citing this
  3. Nunez, J.K., Chen, J., Pommier, G.C., et al.. Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing. Cell (2021). paper; opened 2026-11-17 all records citing this
  4. Cappelluti, M.A., Mollica Poeta, V., Valsoni, S., et al.. Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature (2024). paper; opened 2026-11-17 all records citing this
  5. Roberts, R.. Epigenome editing therapy raises hopes for a functional cure for chronic hepatitis B. The Scientist (2026). news, not peer reviewed; opened 2026-11-17 all records citing this
Where it sits on the map
History of this record (7)

This record has been changed 7 times, on the dates below. The note kept against each change is written for the people who maintain the atlas, in their own shorthand, so it is not shown here; it is in the record itself.

Status
partly written
Last updated
2026-11-19
Record
content/concepts/epigenome-editing.json